Hülya Bayir

University of Pittsburgh

NIH Rank #3539
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$2.5M
Fiscal year 2024
Grants Awarded
5
Active NIH grants
National Rank
#3,539
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.5M across 5 grants · National rank #3539.

Top grants by award amount

Hülya Bayir's NIH grant portfolio, ranked by award amount.

  • 1R01HL174611-01R01
    Selective inhibitors of MLCL/CytC Peroxidase in Barth Syndrome
    $733.8K
    award amount
  • 5R01NS076511-12R01
    Lipid Imaging in Traumatic Brain Injury by High Resolution GCIB-secondary Ion Mass Spectrometry
    $568.8K
    award amount
  • 5R01NS117000-05R01
    Druggable Mitochondrial Targets for Treatment of Cerebral Ischemia
    $552.2K
    award amount
  • 5U01AI156923-05U01
    Radiation Mitigators Targeting Regulated Necrosis Pathways of Parthanatos Pyroptosis
    $358.4K
    award amount
  • 5R37NS061817-14R37
    Oxidative Lipidomics in Pediatric Traumatic Brain Injury
    $317.1K
    award amount

Affiliations

Institutions that have administered grants for Hülya Bayir.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of Pittsburgh
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3539
  6. 2024
    Entered Top 25% Nationally
    Ranked #3539
  7. 2024
    Multi-Institutional Research
    Awards at 2 institutions